Gen Trust, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Gen Trust, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$548.35 - $738.84 $109,670 - $147,768	200 Added 66.67%	500 $296,000
Q1 2022 Apr 14, 2022	SELL	$595.12 - $698.43 $119,024 - $139,686	-200 Reduced 40.0%	300 $210,000
Q4 2021 Feb 07, 2022	BUY	$543.48 - $670.97 $52,174 - $64,413	96 Added 23.76%	500 $307,000
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $2,296 - $2,723	4 Added 1.0%	404 $244,000
Q2 2021 Aug 10, 2021	BUY	$472.8 - $558.54 $189,120 - $223,416	400 New	400 $223,000
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $191,320 - $243,192	-400 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $5,447 - $6,582	-10 Reduced 2.44%	400 $224,000
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $202,261 - $264,007	410 New	410 $256,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Gen Trust, LLC, based on Form 13F filings with the SEC.

Stay updated on Gen Trust, LLC with notifications on news.